Cardio-TriTest vs Acumen Hypotension Prediction Index (HPI) Feature Software

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Cardio-TriTest

by Cardio-Phoenix

Acumen Hypotension Prediction Index (HPI) Feature Software

by Edwards Lifesciences

AI Verdict

Cardio-TriTest is a diagnostic device focused on the earlier and more comprehensive detection of cardiovascular diseases in primary care settings. In contrast, the Acumen Hypotension Prediction Index (HPI) software is a predictive monitoring tool designed to prevent acute hypotensive events in critical care and surgical environments. While both utilize AI in cardiology, their distinct applications for diagnosis versus acute hemodynamic prediction make them suitable for different clinical needs.

Choose Cardio-TriTest if…

Choose Cardio-TriTest if your primary care clinic or internal medicine practice requires a comprehensive, non-invasive diagnostic tool for early and accurate detection of various cardiovascular diseases. This device is ideal for synchronizing and visually correlating multiple heart bio-signals (ECG, PCG, MCG) to provide a more complete picture of cardiac health, aiding in initial screening and risk assessment.

View Cardio-TriTest →

Choose Acumen Hypotension Prediction Index (HPI) Feature Software if…

Choose Acumen Hypotension Prediction Index (HPI) Feature Software if your critical care unit, operating room, or emergency department needs a proactive monitoring solution to prevent hypotensive events. This AI-powered software integrates with existing platforms to predict hypotension up to 15 minutes in advance, enabling clinicians to intervene early and optimize hemodynamic management for improved patient outcomes.

View Acumen Hypotension Prediction Index (HPI) Feature Software →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Cardio-TriTest	Acumen Hypotension Prediction Index (HPI) Feature Software
Deployment	On-premise (device)	Unknown
FDA Status	Unknown	Cleared AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Cardio-TriTest

Cardio-TriTest is a non-invasive, device-based solution designed for primary care, fitting into existing ECG workflows and operated by staff trained in ECG. It offers immediate visual reports, making it straightforward for general practitioners to interpret heart health.

Clinical Value

Acumen Hypotension Prediction Index (HPI) Feature Software

Acumen HPI demonstrates a strong clinical value by providing proactive prediction of hypotensive events up to 15 minutes in advance, with documented reductions in the incidence, duration, and severity of intraoperative hypotension. This directly translates to improved patient outcomes in critical care settings, supported by multiple clinical studies and registries.

Pricing & Value

Tie

Both tools explicitly state that pricing information is not publicly available and requires direct contact with the vendor. This lack of transparency for both products makes it impossible to conduct a head-to-head comparison on pricing or to objectively assess their value proposition upfront.

Enterprise Readiness

Acumen Hypotension Prediction Index (HPI) Feature Software

Acumen HPI, developed by Edwards Lifesciences, a large global medical technology company with substantial revenue and a global presence, is integrated into their HemoSphere advanced monitoring platform and supports HL7 standards for hospital information system connectivity. This indicates a robust solution designed for complex hospital environments and large-scale enterprise deployment.

Innovation

Acumen Hypotension Prediction Index (HPI) Feature Software

Acumen HPI is described as a 'first-of-its-kind technology' that leverages machine learning to provide real-time predictive analytics for impending hypotensive events up to 15 minutes before they occur. This predictive capability for acute, life-threatening situations represents a significant advancement in proactive critical care management.

Support & Docs

Acumen Hypotension Prediction Index (HPI) Feature Software

Edwards Lifesciences offers comprehensive support for Acumen HPI, including 24/7 technical support, extensive clinical education resources, setup guides, FAQs, and case studies. In contrast, Cardio-TriTest's available information only lists a general contact email, lacking specific details on support services or documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Cardio-TriTest	Acumen Hypotension Prediction Index (HPI) Feature Software
Tool Name	Cardio-TriTest	Acumen Hypotension Prediction Index (HPI) Feature Software
Company	Cardio-Phoenix Inc.	Edwards Lifesciences
Description	Cardio-TriTest v6.5 by Cardio-Phoenix Inc. is an AI-powered 3-in-1 diagnostic device combining ECG, PCG, and MCG to synchronize and visually correlate heart bio-signals for earlier and more comprehensive cardiovascular disease detection in primary care.	Edwards Lifesciences' Acumen Hypotension Prediction Index (HPI) software is a predictive monitoring tool that uses machine learning to detect and alert clinicians to the likelihood of a hypotensive event before it occurs, aiding in proactive hemodynamic management and improving patient outcomes.
Key Features	3-in-1 diagnostic device (ECG, PCG, MCG), 12-Lead Electrocardiograph (ECG), 4 Lead Phonocardiograph (PCG), 4 Lead Mechanocardiograph (MCG), Synchronized bio-signal acquisition, Visual correlation of heart bio-signals, AI-powered analysis for heart disease detection, Non-invasive test procedure	Hypotension Prediction Index (HPI) parameter (0-100 score), Smart Alerts and Smart Trend screen for impending hypotensive events, Relationship View screen providing insights into preload, afterload, and contractility, Machine learning algorithms for predictive analysis of blood pressure waveforms, Predicts hypotension up to 15 minutes before an event, Demonstrated reduction in incidence, duration, and severity of intraoperative hypotension, Compatibility with both invasive (arterial line) and non-invasive (Acumen IQ cuff) monitoring, Adjustable Mean Arterial Pressure (MAP) target for hypotension definition
Specialties	Cardiology, Family Medicine, Internal Medicine	Anesthesiology, Critical Care, Emergency Medicine

Videos

Demos, reviews, and walkthroughs featuring Cardio-TriTest and Acumen Hypotension Prediction Index (HPI) Feature Software.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows for their respective specialties, and what specific clinical problems do they primarily address?

Cardio-TriTest is a device-based diagnostic tool designed for primary care, cardiology, and internal medicine, aiming for earlier and more comprehensive cardiovascular disease detection through synchronized bio-signal acquisition. Acumen HPI, integrated into the Edwards Lifesciences HemoSphere platform, is a predictive monitoring software for anesthesiology, critical care, and emergency medicine, focused on detecting and alerting clinicians to impending hypotensive events to enable proactive hemodynamic management.

What level of diagnostic or predictive accuracy can physicians expect from each tool, particularly regarding the timing and reliability of its insights?

Cardio-TriTest aims for earlier and more comprehensive cardiovascular disease detection by visually correlating ECG, PCG, and MCG signals. Acumen HPI has demonstrated high accuracy in predicting hypotensive events up to 15 minutes before they occur, with studies showing a sensitivity of 90% and specificity of 89% at 10 minutes prior to an event.

What unique visual or analytical insights does each tool provide to aid clinical decision-making?

Cardio-TriTest offers visual correlation of synchronized heart bio-signals (ECG, PCG, MCG) to assist in broader diagnostic interpretation. Acumen HPI provides a numerical score (0-100) indicating the likelihood of hypotension, along with Smart Alerts, Smart Trend screens, and a Relationship View that offers insights into preload, afterload, and contractility to help identify the root cause of hemodynamic instability.

What is the anticipated learning curve for physicians and their teams to effectively utilize each tool, and what kind of training might be involved?

While specific training details for Cardio-TriTest are not provided, as a diagnostic device, it would likely involve training on device operation and interpretation of its multi-signal visual output. Acumen HPI, being integrated software, requires familiarity with its HPI parameter, Smart Alerts, and Relationship View, with training often provided in medical centers that routinely use HPI monitoring.

What features do these tools offer for reviewing past patient data, auditing clinical decisions, or assessing the tool's performance over time?

Cardio-TriTest, as a diagnostic device, generates reports that can be stored and reviewed for individual patient cases. Acumen HPI, through its integration with the HemoSphere platform and Acumen Analytics software, allows for retrospective viewing and analysis of monitored hemodynamic parameters, including the frequency, duration, and prevalence of intraoperative hypotension in practice.

What are the key considerations for implementing and scaling each tool across multiple clinical sites or departments within a healthcare system?

For Cardio-TriTest, a device-based solution, multi-site rollout would involve the physical deployment of devices and staff training at each location. Acumen HPI, as software integrated into the HemoSphere platform, would involve software licensing, integration with existing monitoring infrastructure, and standardized training across departments or sites utilizing the HemoSphere system.

How do these tools facilitate data flow into patient records or other hospital systems?

Cardio-TriTest, as a diagnostic device, would typically generate reports that can be integrated into patient records, likely through exportable formats. Acumen HPI, being integrated into the Edwards Lifesciences HemoSphere advanced monitoring platform, facilitates real-time data flow and can be used with Acumen Analytics software for retrospective data analysis, which can then be downloaded and organized.